<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03031080</url>
  </required_header>
  <id_info>
    <org_study_id>5396</org_study_id>
    <nct_id>NCT03031080</nct_id>
  </id_info>
  <brief_title>BOND Study: the Benefit Of Night Splinting in Dupuytrens'</brief_title>
  <acronym>BOND</acronym>
  <official_title>The Effectiveness of Night Splinting After Collagenase Injection for Dupuytren's Contracture</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royal Liverpool and Broadgreen University Hospitals NHS Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Royal Liverpool and Broadgreen University Hospitals NHS Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The BOND study is a prospective, randomised single blinded controlled trial to assess the
      effect of night splinting in patients who have had collagenase injection and manipulation
      therapy for Dupuytren's Contracture.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial will assess the effectiveness of night splinting in Dupuytrens' contracture on
      functional and quality of life outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomised Controlled Trial - Block Randomisation</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Initial heath-care provider and participant are not masked as would be impossible to do so. Outcome assessor (a different health care provider) and investigators will be masked as to whether the patient is in the splinted or unsplinted cohort.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Range of motion</measure>
    <time_frame>At 0 weeks, 12 weeks and 52 weeks</time_frame>
    <description>To assess change in range of motion measured in degrees between pre-treatment, immediately post-treatment, 12 weeks post-treatment and 12 months post-treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>PEM Questionnaire</measure>
    <time_frame>At 0 weeks, 12 weeks and 52 weeks</time_frame>
    <description>Patient Evaluation Measure to give disability score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>URAM Questionnaire</measure>
    <time_frame>At 0 weeks, 12 weeks and 52 weeks</time_frame>
    <description>Hand specific outcome questionnaire to assess quality of life outcomes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Dupuytren Contracture</condition>
  <arm_group>
    <arm_group_label>Splinted</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will be given Thermoplastic Hand Splint to wear overnight for 12 weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Un-Splinted</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will not wear a night splint</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Thermoplastic Hand Splint</intervention_name>
    <description>Thermoplastic Night splint created and moulded to the individual patients hand in-house using generic thermoplastic.</description>
    <arm_group_label>Splinted</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Single digit contractures greater than 30 degrees

          2. No prior surgery for their contractures.

          3. Successful collagenase and manipulation therapy (contracture reduced to within 10
             degrees of full extension).

        Exclusion Criteria:

          1. Multiple digit contractures

          2. Prior surgery for their contractures.

          3. Failure of collagenase and manipulation therapy (contracture not reduced to within 10
             degrees of full extension).

          4. Inability to consent to treatment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Graham Cheung, MBBCh FRCS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Consultant Hand Surgeon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Royal Liverpool &amp; Broadgreen University Hospitals NHS Trust</name>
      <address>
        <city>Liverpool</city>
        <state>Merseyside</state>
        <zip>L7 8XP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2017</study_first_submitted>
  <study_first_submitted_qc>January 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2017</study_first_posted>
  <last_update_submitted>April 10, 2018</last_update_submitted>
  <last_update_submitted_qc>April 10, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Collagenase, Night-splinting, Dupuytrens, Contracture</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contracture</mesh_term>
    <mesh_term>Dupuytren Contracture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

